Location History:
- South San Francisco, CA (US) (1995)
- San Francisco, CA (US) (1995 - 1999)
Company Filing History:
8 out of 3,221 
1 out of 769 
1 out of 1,373 
Years Active: 1995-1999
Title: Caroline Alice Hebert: Innovator in Monoclonal Antibody Research
Introduction
Caroline Alice Hebert is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies for the treatment of asthma and inflammatory conditions. With a total of 10 patents to her name, Hebert's work has had a substantial impact on therapeutic strategies in modern medicine.
Latest Patents
Among her latest patents, Hebert has developed methods for the treatment of asthma using anti-IL-8 monoclonal antibodies. These innovative methods provide new avenues for managing asthma symptoms effectively. Additionally, she has identified cDNAs encoding a class of receptors, including IL-8 receptors, in human tissue. Her work with recombinantly produced PF4ARs has facilitated the preparation and purification of antibodies that bind to these receptors, which are crucial in diagnostic assays. The antibodies developed through her research are particularly advantageous in preventing and treating various inflammatory conditions.
Career Highlights
Hebert has worked with notable companies in the biotechnology sector, including Genentech, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Kyung Jin Kim and Sherman Fong. Their collaborative efforts have further advanced the research and development of monoclonal antibodies.
Conclusion
Caroline Alice Hebert's innovative work in monoclonal antibody research has positioned her as a key figure in the field. Her contributions continue to influence therapeutic approaches to asthma and inflammatory diseases.